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Abstract 
Cationic liposomes are used as the carriers of polyanionic genes for combating against hereditary diseases in gene therapy. 
Studies directed to careful biophysical characterizations of the cationic liposomes commonly used in gene delivery have just 
begun. Herein, we report on a novel iposomal exo-surface bound indazolization reaction of an amphiphilic arenediazonium 
salt as evidence for the existence of remarkably alkaline exo-surface of cationic liposomes commonly used in gene 
transfection. Our results demonstrate hat formation of 5-hexadecyl-7-methylindazole in thermal indazolization of 2,6- 
dimethyl-4-hexadecylbenzenediazonium tetrafluoroborate bound to liposome surface is a strong indication for the existence 
of significantly high exo-surface pH for cationic liposomes commonly used in gene delivery. The present method can be used 
in determining the relative xo-surface basicities of various cationic liposomes used in gene transfection and subsequently to 
find any possible correlation between the transfection efficiencies of these liposomes and their exo-surface basicities. © 1998 
Elsevier Science B.V. All rights reserved. 
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1. Introduction 
Transfection vectors including retrovirus [1,2], ad- 
enovirus [3], cationic liposomes [4-13], etc., are used 
as the carriers of polyanionic genes for combating 
against hereditary diseases in gene therapy. Repro- 
Abbreviations: DOPE, 1,2-dioleoyl-sn-glycero-3-phosphatidyl- 
ethanolamine; DOTAP, N-[1-(2,3-dioleoyloxy)propyl]-N,N,N-tri- 
methylammonium chloride; DOTMA, N-[1-(2,3-dioleoyloxy)- 
propyl]-N.N,N-trimethylammonium chloride; DHDAB, 
dihexadecyl-dimethylammonium bromide; 16-Ind, 5-hexadecyl- 
7-methylindazole; 1-Ind, 5,7-dimethylindazole 
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ducibility, high degree of targetability and low cellu- 
lar toxicity associated with cationic liposomal trans- 
fection vectors have generated an unprecedented 
upsurge of multidisciplinary interests in developing 
efficient liposomal gene delivery vehicles. Since the 
first report of cationic lipid mediated gene delivery 
by Felgner et al. [4], an impressive number of effi- 
cient liposomal transfection vectors have been syn- 
thesized [14-23]. The key factors governing DNA-  
lipid interactions are still poorly understood. Reports 
on the structural details of the complexes between 
the cationic liposomes and DNA are appearing al- 
most in every issue of the relevant scientific journals 
[6,7,15,24-41]. On the contrary, studies directed to 
careful biophysical characterizations of the cationic 
liposomes commonly used in gene delivery have just 
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begun. Nantz and coworkers [15] recently studied the 
correlation of lipid hydration with in vivo transfec- 
tion activity, and demonstrated that cationic lipids 
possessing the greatest imbalance between the effec- 
tive cross-sectional areas occupied by their polar and 
hydrophobic domains are the most active transfec- 
tion agents. They have also studied the counterion 
influence on the cationic lipid mediated transfection 
of plasmid-DNA [32]. The first step in the liposomal 
transfection process, namely, the formation of com- 
plexes between the negatively charged DNA and the 
cationic liposomes, is dictated by electrostatic nter- 
actions. The surface charge of a cationic liposome 
and the DNA-lipid interactions are most likely to 
be dependent on the interfacial pH. Using a pH-sen- 
sitive fluorophore, Zuidam and Barenholz [26] have 
recently studied the electrostatic parameters of the 
cationic liposomes commonly used in gene delivery, 
and have demonstrated the presence of a large pos- 
itive surface potential and a high pH at the cationic 
liposomal surface. In their most recent work [42], 
they have also demonstrated that the electrostatic 
parameters play a key role in the formation of 
DNA-lipid complexes. Herein, we report on a novel 
liposomal exo-surface bound indazolization reaction 
of an amphiphilic arenediazonium salt as evidence 
for the existence of remarkably alkaline exo-surface 
of cationic liposomes commonly used in gene trans- 
fection. Our results demonstrate hat formation of 5- 
hexadecyl-7-methylindazole in thermal indazolization 
of 2,6-dimethyl-4-hexadecylbenzenediazonium tetra- 
fluoroborate bound to liposome surface is a strong 
indication for the existence of significantly high exo- 
surface pH for cationic liposomes commonly used in 
gene delivery. 
2. Mater ia ls  and methods 
2.1. Materials 
2,6-Dimethyl-4-hexadecyl benzene diazonium tet- 
rafluoroborate (16-ArNfBF4) and 1-ArN+BF4 
were synthesized following the procedure described 
in Refs. [43,44]. 1,2-Dioleoyl-sn-glycero-3-phospha- 
tidylethanolamine (DOPE), dihexadecyl-dimethylam- 
monium bromide (DHDAB), benzyl bromide, tri- 
methyl silyl iodide and rac-l,2-isopropylidene-sn- 
glycerol were purchased from Fluka (Switzerland) 
and used without further purification. Amberlyst A- 
26 chloride ion exchange resin and rac-3-(dimethyl- 
amino)-l,2-propanediol were purchased from Lan- 
caster, UK and Aldrich, USA. Cholesterol was pur- 
chased from Loba Chemicals (India) and was 
crystallized two times from methanol before use. 
All the other reagents used in the synthesis were 
procured from Spectrochem (India) and were of 
highest analytical grade. All the solvents used were 
of HPLC grade and were purchased from Qualigens 
(India). 
2.2. Synthesis 
The reported synthesis of DOTMA (N-[1-(2,3-di- 
oleoyloxy)propyl]-N,N,N-trimethylammonium chlo- 
ride) [4] consists of dioleoylation of rac-3-(dimethyl- 
amino)-l,2-propanediol with oleoyl p-toluene 
sulfonate in xylene at high temperature followed by 
quaternization of the resulting tertiary amine using 
condensed methyl chloride at 70°C in a sealed Paar 
apparatus. There are neither any yield reports at any 
step nor any spectral characterization of the final 
Scheme I. Synthesis of DOTMA 
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Reagents : (a) Oleyl Mesylate(2.2eqv)/KOH O0 eqv)/ 
Xylene/6 hrs; (b) TMSI (6 eqv)/DCM/14 hrs; 
(c) TsCI (3 eqv)/DMAP (3 eqv)/DCM/0°C-R.T. 43 hrs; 
(d) Me3N-MeOH/60°C/sealed tube/48 hrs; (e) Amberlyst 
A-26 chloride ion exchange resin. 
Scheme 1. 
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product in this published synthesis of DOTMA, and 
for this reason we felt the need to develop a well 
characterized chemical synthesis of DOTMA, the de- 
tails of which are outlined below. 
2.2.1. Synthesis" of DOTMA 
DOTMA was synthesized from rac-3-O-benzyl-sn- 
glycerol 1 (prepared by conventional benzylation of 
rac-l,2-isopropylidene-sn-glycerol using sodium hy- 
dride and benzyl bromide in dry dimethylformamide 
under nitrogen followed by quantitative deprotection 
of isopropylidene group by refluxing it in 80:20 (v/v) 
methanol/water containing few drops of added con- 
centrated hydrochloric acid) in five steps as outlined 
in Scheme 1 with an overall yield of 41%. Dioleo- 
ylation [45] of 1 (1.22 g, 6.7 mmol) with 30 eq. of 
dried and powdered potassium hydroxide and 4.9 g 
(14 mmol) of oleoyl mesylate (prepared in three steps 
from commercially available oleic acid in overall 77% 
yield: (a) MeOH/2% H2SO4/6 h reflux; (b) LAH (3 
eq.)/THF/0°C 3 h; and (c) CH3SOzC1 (1.5 eq.)/Py 
(1.5 eq.)/DMAP (cat)/DCM/0°C R.T./6 h) was car- 
ried out by refluxing in xylene for 6 h using a Dean- 
Stark apparatus. After removing xylene by distilla- 
tion, the residue was extracted with 150 ml diethyl 
ether. The ether extract was washed thoroughly with 
water, dried with anhydrous odium sulfate, filtered, 
and ether was rotavapored from the filtrate. Pure 
dioleoyl product 2 (3.6 g, 78.6% yield from 1) was 
isolated from the residue by silica gel column chro- 
matography using 8-10% ethyl acetate in pet-ether as 
the eluent. The benzyl group of 2 was then removed 
with trimethylsilyl iodide (7.35 g, 36 mmol) in dry 
dichloromethane following the protocol described 
in Ref. [46]. Tosylation of the resulting debenzylated 
compound 3 (3.2 g, 100% yield from 2) was carried 
by stirring with p-tosyl chloride (3 g, 15.7 mmol) and 
DMAP (2.1 g, 17.2 mmol) in dry dichloromethane at 
room temperature for 40 h. The dichloromethane 
was removed by rotatory evaporation, and pure to- 
sylated product 4 (2.7 g, 70% yield from 3) was iso- 
lated from the residue by silica gel column chroma- 
tography using 2-5% ethyl acetate in pet-ether as the 
eluent. Quaternization of 4 with methanolic trimeth- 
ylamine in a sealed tube for 20 h at 60-65°C afforded 
N-[ l-(2,3-dioleoyloxy)propyl]-N,N, -trimethylammo- 
nium tosylate (2.9g, 3.6 mmol) 5, in 100% crude 
yield from 4. The crude quaternary salt 5 was not 
purified. It was dissolved in chloroform, loaded over 
a freshly generated Amberlyst A-26 chloride ion ex- 
change column, and eluted with chloroform. After 
evaporating the eluent chloroform, pure DOTMA 
(1.8 g, 75% yield from 5) was finally obtained by 
recrystallization of the residue from acetone at 
- 18°C .  
lH-NMR of DOTMA (400 MHz, CDCI3)" ~/ 
ppm=0.88 (t, 6H, CH3-C17H32-); 1.20-1.34 (m, 
44H,-(CH2), - ) ;  1.58 (m, 4H, -CH2-CH2-O-) ;  
1.90-2.08 (m, 8H, -CH2-CH=CH-CH2- ) ;  3.34- 
3.48 (2t, 4H, -CH2-CH2-O-); 3.54 (s, 9H, 
(CH3)3 N+ ); 3.60 (dd, 1H, HICH2OR-CHOR -
CH2-N÷(CH3)3); 3.68 (m, 2H, CH2OR CHOR- 
CH2-N+(CH3)3); 4.03 (dd, 1H, H1CH2OR - 
CHOR CH2-N+(CH3)3); 4.09 (m, 1H, FIICH2OR - 
CHOR-CH2-N+(CH3)3); 5.32 (m, 4H, CH2- 
cI- I  = C_H-CH2-) .  
HRMS (FABS) m/z: Calcd (for C42H84NO2, the 
4°-ammonium ion) 634.6502, found 634.6484. 
2.2.2. Synthesis of 5-hexadecyl-7-methylindazole 
(16-Ind) 
2.6 g (7.13 mmol) hexadecyl trimethyl ammonium 
bromide (CTAB) was dissolved in 500 ml 20 mM 
aqueous phosphate buffer (pH 7.0) to prepare a cat- 
ionic micellar solution. 110 mg (0.25 mmol) of 16- 
ArN~-BF 4 dissolved in 10 ml HPLC grade acetoni- 
trile was added to the micellar solution and the sol- 
ution was kept stirred overnight (12 h). The solution 
turned light yellow, and 1.5 g (10.7 mmol) of sodium 
perchlorate monohydrate was added to this yellow 
solution. Immediately, a heavy white precipitate ap- 
peared. The precipitate was filtered and washed with 
a copious amount of water. The washed precipitate 
was air-dried using a water aspirator for 4 h and 
finally the air-dried precipitate was vacuum-dried 
for 2 h. The dried precipitate was then extracted 
with ether (3 × 200 ml). The combined ether extract 
was dried with anhydrous odium sulfate and fil- 
tered. The ether was removed from the filtrate using 
a rotatory evaporator and 16-Ind was isolated from 
the residue by silica gel column chromatography, 
changing the eluent from pet-ether to pet-ether/ethyl 
acetate (88:12, v/v). The fractions with Rf = 0.6 (us- 
ing 60:40 pet-ether/ethyl acetate, the TLC developing 
solvent) were combined and the solvent was evapo- 
rated. The white residue left after evaporation of the 
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solvent afforded 50 mg of pure 16-Ind (57% yield) 
upon crystallization from acetone. 
1H-NMR of 16-Ind (200 MHz, CDCI3): 5/ 
ppm=0.88 (t, 3H, CH3-C15H31-); 1.20-1.34 (m, 
26H,-(CHz)n-);  1.68 (m, 2H,-CH2-CH2-Ar) ;  
2.50 (s, 3H, CH3-Ar); 2.68 (t, 2H, -CH2-CHz-  
Ar); 7.0 (s, 1H, ArH para to -CH=N-) ;  7.37 (s, 
1H, ArH ortho to -CH=N-) ;  8.0 (s, 1H, Ar 
CH = N-NH-Ar). 
HRMS m/z: Calcd (for C24H40N2) 356.3192, 
found 356.3196. 
2.2.3. Synthesis of 5, 7-dimethylindazole (1-Ind) 
1.0 g (4.27 mmol) of 1-ArNfBF 4 was added to 
500 ml aqueous 0.1 M NaOH solution and the sol- 
ution was kept stirred overnight (12 h). The reddish- 
orange solution was then extracted with ether 
(3 × 200 ml). The combined ether extract was dried 
with anhydrous sodium sulfate and filtered. The 
ether was removed from the filtrate using rotatory 
evaporator and 1-Ind was isolated from the red res- 
idue by silica gel column chromatography, changing 
the eluent from pet-ether to pet-ether/ethyl acetate 
(80:20, v/v). The fractions with R~=0.4 (using 
50:50 pet-ether/ethyl acetate, the TLC developing 
solvent) were combined and the solvent was evapo- 
rated. The light yellow solid residue left after evap- 
oration of the solvent afforded 70 mg of pure white 
1-Ind (11.2% yield) upon activated norit treatment in
hot methanol followed by crystallization from ethyl 
acetate containing a few drops of methanol. 
IH-NMR of 16-Ind (200 MHz, CDC13): ~5l 
ppm=2.38 (s, 3H, CH3-Ar para to -NH-);  2.50 (s, 
3H, CH3-Ar ortho to -NH-);  6.9 (s, 1H, ArH para 
to -CH=N-) ;  7.28 (s, 1H, ArH ortho to -CH=N-) ;  
7.9 (s, 1H, Ar -CH=N NH-Ar). 
HRMS m/z: Calcd (for CsHI0N2) 146.0844, found 
146.0843. 
2.2.4. Synthesis of DOTAP 
DOTAP (N-[1-(2,3-dioleoyloxy)propyl]-N,N,N-tri- 
methylammonium chloride) was synthesized basically 
following the protocol reported by Leventis and Sil- 
vius [23]. The iodide counterion was exchanged with 
chloride ion by ion-exchange chromatography using 
an Amberlyst A-26 chloride ion exchange column. 
IH-NMR of DOTAP (200 MHz, CDCI3): 6/ 
ppm=0.88 (t, 6H, CH3-CHz-C15Hz8-); 1.20-1.40 
(m, 40H,-(CH2)n-); 1.50-1.68 (m, 4H, -CH2- 
CH2-CO-O-); 1.90-2.08 (m, 8H, -CH2-CH=CH-  
CH2-); 2.21-2.40 (2t, 4H, -CH2-CH__2-CO-O-); 3.42 
(s, 9H, (CH3)3N+-); 3.70--3.90 (m, 1H, CH2OCOR- 
CHOCOR-H1H2C-N+(CH3)3); 4.02-4.18 (m, 1H, 
CH2OCOR-CHOCOR-H1H2C-N+(CH3)3); 4.21 
4.38 (m, 1 H, H 1CH2OCOR-CHOCOR-CH2 
N+(CH3)3); 4.45-4.59 (m, 1H, HICH2OCOR -
CHOCOR-CH2-N+(CH3)3); 5.32 (m, 4H, -CH2- 
CH=CH-CH2-); 5.61 (m, 1H, CH2OCOR-CHOC- 
OR-CH2-N+(CH3)3). 
HRMS (LSIMS) m/z: Calcd (for C42H80NO4, the 
4°-ammonium ion) 662.6087, found 662.6089. 
2.3. Methods 
2.3.1. High-performance liquid chromatography 
(HPLC) 
The yields of both the short-chain and the long- 
chain indazole products (1-Ind and 16-Ind, respec- 
tively) were determined by quantitative HPLC. The 
LC system consisted of a Shimadzu Model LC10A 
and a Hewlett Packard HP series 1050 high-perform- 
ance liquid chromatograph. A 20%tl sample loop was 
used for quantitative determination of both l-Ind 
and 16-Ind. The wavelength of the UV detector 
was set at 212 nm in an HP series 1050 HPL chro- 
matograph for detection of 1-Ind. The separation of 
the 1-Ind from other products was effected on a 
4.6x250 mm Whatman reverse phase C18 column. 
The mobile phase used was acetonitrile/water (60:40, 
v/v) with a flow gradient where the initial flow rate 
(0.6 ml/min) was maintained up to 8.0 min and 
changed to 1.5 ml/min at 13.0 rain. This final flow 
rate was maintained for 12 min before returning to 
the initial flow rate. 16-Ind was detected in a Shi- 
madzu Model LC10A HPL chromatograph using a 
UV detector at the wavelength of 219 nm. 16-Ind 
was separated from the other products using a 
3.5 × 150 mm Nova-Pak C18 (Waters) steel cartridge 
column. The initial flow rate (0.6 ml/min) was line- 
arly increased to 1.0 ml/min at 25.0 min using a 
constant mobile phase acetonitrile/methanol/isopro- 
panol/water (100: 75: 70: 9.5, v/v). 
2.3.2. Preparation of small unilamellar liposomes with 
bound 16-ArN~ B~44 
The lipid mixtures in the desired ratio were dis- 
R. Banerjee et aL / Biochimica et Biophysica Acta 1373 (1998) 299-308 303 
solved in chloroform in a glass vial. The chloroform 
was removed with a thin flow of moisture-free nitro- 
gen and the dried film of lipid left in the vial was 
then kept under high vacuum for 8 h. Five ml aque- 
ous buffer was added to the vacuum-dried lipid film 
and the mixture was allowed to swell for 15 h (over- 
night). The hydrated lipid mixture was then soni- 
cated at 60-70°C in a ULTRAsonik 28X bath soni- 
cator at maximum power for 10 min. The resulting 
multilamellar vesicles were sonicated at 100% duty 
cycle and 25 W output power in a Branson 450 Ti- 
probe sonicator for 3-5 min. The translucent solu- 
tions were finally extruded five times through 50-nm 
pore size polycarbonate membranes under a 200-300 
p.s.i, nitrogen pressure using a Lipex Biomembrane 
Extruder system. To 1.5 ml of the resulting optically 
almost transparent small unilamellar liposomes were 
added 15 ~tl of an appropriate stock solution of the 
exo-surface basicity sensor, 16-ArN~-BF 4, so that in 
all the experiments he molar ratio of lipid to surface 
basicity sensor were 100 or 50 to 1. 
3. Results and discussion 
3.1. Background 
Romsted and his coworkers have demonstrated 
that the local molar concentrations of water, coun- 
terion and alcohol co-surfactant in the interfacial 
region of CTAB-based cationic microemulsions can 
be determined using the product distribution of the 
interface-bound ediazoniation reaction of (16- 
ArN+BF4), an amphiphilic arene diazonium salt 
[43,44]. In this method for determining the interfacial 
concentrations, the aggregate-bound probe molecule 
is allowed to undergo thermal dediazoniation reac- 
tion in presence of acid in the dark. The relative 
amounts of the three dediazoniation products 
namely, 16-ArOH, 16-ArBr and 16-ArOHex (deter- 
mined quantitatively by HPLC analysis of the dedi- 
azoniation product mixtures) were shown to be de- 
pendent on the local molar concentrations of water, 
bromide ions and n-hexanol, respectively (Scheme 2). 
In our pursuit of deciphering any possible correlation 
existing between the transfection efficiencies of vari- 
ous cationic liposomes and the exo-surface concen- 
trations of water and counterions, we decided to ex- 
tend the use of the same interfacial probe (16- 
ArN+BF4) for determining the local molar concen- 
trations of water and counterions present in the in- 
terfacial regions of various small unilamellar cationic 
liposomes prepared at pH 7.0. To our utter surprise, 
the HPLC chromatograms for the product mixtures 
formed from the cationic liposome-bound reaction of 
the probe molecule showed a significant new peak 
right after the 16-ArOH peak in all the chromato- 
grams. The same product was also formed in signifi- 
cant yields when the probe molecule was dissolved in 
aqueous CTAB at pH 7 and the micellar solution 
was heated at 50°C. Isolation in pure form followed 
by NMR, high-resolution mass spectral characteriza- 
tion of the purified product (as described in Section 
2.2.2) and HPLC spiking experiment conclusively re- 
vealed the identity of the peak that appeared after 
the 16-ArOH peak as 5-hexadecyl-7-methylindazole 
(16-Ind in Fig. 1). More than three decades back, in 
Scheme I I  
(A) lnterfacial dediazoniation of CTAB-based cationic 
microemulsion associated interfaciai probe. 
CH 3 CH3 CH 3 
16_ArN2 + 16.Ar + 16=ArOH when z = OH 
16-ArBr when z = Br 
(Interracial Probe) 16-ArOHex when z = OHex 
(B) lndazolization of 16-ArNz ÷ associated with the exo- 
sur face of cationic liposomes used in gene delivery. 
H3 3 OH. H3C~, /CH 
CH 3 CH3 
16.ArN2 + 16-1nd 
(Interracial Probe) 
Scheme 2. 
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Mkaline Exo-surface 
o: 16-ArN2 + o 
Interracial 
lndazol izat ion 
~ 6-1nd 
Fig. 1. Indazolization of 2,6-dimethyl-4-hexadecylbenzenediazonium salt (16-ArN~) bound to the exo-surface of a cationic liposome. 
their investigations on the rearrangement of benze- 
neazotribenzoylmethane and its derivatives, Curtin 
and Poutsma [47] reported the formation of 5,7- 
dimethylindazole (1-Ind in Scheme 3) in low yield 
(9%) when 2,4,6-trimethyl benzene diazonium 
salt was treated with strong alkali. This report sug- 
gested to us that the origin of formation of 16-Ind 
(Scheme 2) in the liposome-associated conver- 
sion of 16-ArN2~BFg is probably the remark- 
able alkaline exo-surface of the cationic liposomes 
(Fig. 1). 
3.2. Correlation between %l-Ind and pH in the 
non-liposomal indazolization 
The yields of indazole not being the main focus of 
their investigations, Curtin and Poutsma, in their re- 
port [47], did not mention anything about the de- 
pendence of 1-Ind yield on the alkali concentrations. 
We decided to carry out a detailed HPLC-based 
product distribution study for establishing the corre- 
lation between the yields of 1-Ind and the concentra- 
tions of alkali. The results hown in Table 1 demon- 
strate that within the pH range 9-12.5, the yields of 
indazole product increase with increasing solution 
pH, and when the pH of the solution exceeds 12.5 
the yields of 1-Ind decrease again. As to the origin of 
formation of the indazole product from short-chain 
diazonium salt in alkaline pH, we propose the mech- 
anistic route shown in Scheme 3. The indazole prod- 
uct is likely to result via the formation of the syn- 
hydroxy azoate intermediate III formed in the alka- 
line media. Intramolecular bstraction of a proton 
from the ortho-methyl group results in the formation 
of carbanion IV which then expels the hydroxide ion, 
intramolecularly yielding intermediate V. The inter- 
mediate V finally undergoes aromatization to form 1- 
Ind. Obviously, the intramolecular p oton abstrac- 
tion from the ortho-methyl group is feasible only 
with syn-hydroxy azoate intermediate II1 and not 
with its trans-isomer VII (Scheme 3). The formation 
of such syn-hydroxy azoate from diazonium salts in 
the presence of alkali and the isomerization of syn- 
azoate to its trans-isomer in strongly alkaline me- 
dium has already been reported [48-50]. Thus, most 
likely the isomerization of the syn-hydroxy azoate 
intermediate III to the corresponding trans-isomer 
VII (Scheme 3) results in the observed low yields of 
1-Ind when the pH of the solution exceeds 12.5 (Ta- 
ble 1). 
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3.3. Liposomal indazolization of 16-ArNiBF; 
The indazolization pathway shown in Scheme 3 is 
not likely to be mechanistically different when the 
interfacial probe (16-ArNlBF;) undergoes indazoli- 
zation at the exo-surface of cationic liposomes. Be- 
cause of its surfactant-like structure, the interfacial 
probe molecule (16-ArNiBF;), when added to cati- 
onic liposomes, is likely to position its polar diazo- 
nium group in the hydrated and polar exo-surface 
region of the various cationic liposomes (Fig. 1). 
Thus, the reactive diazonium group of the interfacial 
probe experiences an essentially aqueous environ- 
ment of the liposomal exo-surface and being used 
in l-2 mol% with respect to the liposome-forming 
cationic lipid, the probe causes minimum perturba- 
tion of the liposome structure. However, caution 
Scheme III : Plausible mechanism for alkali-induced indazolization of 
o-Methyl beozenedlazonium salts 
H- M 
H3C 
- ---b =I H 
Scheme 3. 
kH, 
l-lnd 
Table 1 
Observed yields” of 1-Ind for non-liposomal indazolization of 
I-ArNi within the pH range 9914 
pHb %I Yields of 1-Ind 
9.0 3.2 
9.2 4.5 
9.4 5.8 
9.6 1.1 
9.8 10.8 
10.0 14.4 
10.2 17.6 
10.4 22.6 
10.6 27.4 
10.8 30.9 
11.0 35.8 
11.2 39.2 
11.4 40.6 
11.6 43.5 
11.8 46.0 
12.0 50.8 
12.5 50.6 
13.0 47.6 
13.5 45.5 
14.0 34.5 
“The yields of 1-Ind were determined through quantitative 
HPLC analysis of the product mixtures using the HPLC cali- 
bration graph for independently synthesized pure I-Ind. The de- 
tails of the HPLC conditions are described in Section 2. The 
non-liposomal indazolization was carried out by heating 
1 x lop4 M aqueous solution of the short-chain diazonium salt 
at 40°C for 6 h. The yields are reproducible within + 1% for 
duplicate experiments. 
bThe aqueous solutions within the 9.0-12.0 pH range were pre- 
pared using 20 mM Na2COJNaHCOs buffer solutions. The pH 
range 12.5-14.0 was maintained using aqueous NaOH solu- 
tions 
should be exercised at this point. The dielectric con- 
stants of the hydrated interfacial regions of lipo- 
somes are generally less than that of bulk water 
[51]. Therefore, possible medium effects on the vari- 
ous steps involved in the formation of indazole 
(Scheme 3) during the liposomal exo-surface associ- 
ated indazolization cannot be ruled out. In other 
words, the correlation between the 16-Ind yield and 
the liposomal exo-surface pH can never be identical 
to that between the 1-Ind yield and the pH of the 
aqueous buffer solutions observed in the non-liposo- 
ma1 aqueous indazolization of l-ArNlBF, (Table 
1). The short-chain indazolization results (Table 1) 
demonstrate that the onset of non-liposomal indazo- 
lization is around pH 9, and higher indazole yields 
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are obtained in the pH range 10.4-12.5. Given this 
high pH requirement for the formation of significant 
indazole and assuming minimal medium effects, the 
observed significant yields (23-32% , Table 2) of 16- 
Ind in most of the liposomal exo-surface bound in- 
dazolizations indicate that the exo-surface of the cat- 
ionic liposomes commonly used in gene delivery are 
remarkably alkaline. The most remarkable f ature of 
the results hown in Table 2 is the fact that the pH of 
the aqueous Hepes buffer solutions used to prepare 
the cationic liposomes were all near 7.0 and yet the 
yields of 16-Ind are in the range of 23-32%. In the 
non-liposomal indazolization, comparable yields (23- 
32%) of l-Ind are obtained at solution pH 10.5-11.0 
(Table 1). Thus, assuming minimal medium effects in 
the alkali-induced indazolization, the observed yields 
of 16-Ind in liposomal exo-surface bound indazoliza- 
Table 2 
Observed yields of 16-1nd a for liposomal exo-surface bound in- 
dazolization of 16-ArN~- 
Liposome b % Yields of 16-1nd 
DOTAP c 31.8 
32.7 
DOTAP/cholesterol a (molar ratio 1:1) 23.9 
24.4 
DOTAP/DOPE d (molar ratio 1:1) Nil 
DOTMA c 23.1 
22.4 
DOTMA/cholesterol d (molar ratio 1 : 1) 31.7 
32.5 
DOTMA/DOPE d (molar ratio 1:1) Nil 
DHDAB c 28.6 
29.9 
DHDAB/cholesterol J (molar ratio 1:1) 41.4 
40.1 
aThe final concentrations of 16-ArN~- were maintained in the 
range 1×10 -4 to 5X10 -5 M. The yields of 16-Ind (data for 
duplicate experiments are shown) were determined through 
quantitative HPLC analysis of the product mixtures using the 
HPLC calibration graph for independently synthesized pure 16- 
Ind. The details of the HPLC conditions are described in Sec- 
tion 2. 
ball the liposome solutions were prepared in 10 mM aqueous 
Hepes buffer (pH 7.0). The details for liposomal indazolization 
are described in the text. 
CThe concentrations of lipid used in preparing pure cationic lip- 
osomes were 5 mM. 
dThe concentration of each lipid was 2.5 mM when the lipo- 
somes were prepared using 1 : 1 molar ratio of cationic lipid and 
the auxiliary lipid (either DOPE or cholesterol). 
tion (Table 2) strongly indicate that the local exo- 
surface pH for cationic liposomes used in gene trans- 
fection are in the range of 10.5-11.0. In other words, 
the molar concentrations of hydroxide ions in the 
exo-surface of the cationic liposomes commonly 
used in gene delivery are orders of magnitude higher 
than the hydroxide ion concentrations in the bulk 
aqueous Hepes buffer solutions (pH 7.0) used to pre- 
pare these liposomes. That the medium effects on the 
alkali-induced indazolization reactions (our basic as- 
sumption) are indeed minimal is strongly supported 
by the recent measurement of surface pH for cationic 
liposomes used in gene delivery by Zuidam and Ba- 
renholz [26] through a completely independent meth- 
od. Using a pH-sensitive fluorophore 4-heptadecyl-7- 
hydroxycoumarin, Zuidam and Barenholz have 
measured the liposomal surface pH in 20 mM Hepes 
buffer (pH 7.4) for various cationic liposomes com- 
monly used in gene transfection, and the value re- 
ported by them for cationic liposomes made from 
DOTAP is 11.6 [26]. If there is zero medium effect, 
the observed average percentage yield of 16-Ind 
(32.3%, Table 2) for indazolization in liposomes 
made from DOTAP when compared with non-lipo- 
somal data (Table 1) indicates that the exo-surface 
pH of cationic liposomes made from DOTAP is 
about 11. Given that there has to be some medium 
effect in the alkali-induced indazolization, our result 
for the DOTAP-based liposomes is consistent with 
the recently reported results of Zuidam and Baren- 
holz [26]. The yields of 16-Ind observed for DOTAP/ 
cholesterol-based liposome, a liposomal vector that 
has recently been demonstrated [7] to have signifi- 
cantly improved gene transfection efficiency, is lower 
than the observed yield of 16-Ind for liposomes made 
from only DOTAP (Table 2). This is expected be- 
cause the auxiliary lipid cholesterol is going to reduce 
the positive charge density at the liposomal surface. 
The exo-surface, because of its reduced positive 
charge density, concentrates fewer hydroxide ions 
at the liposome surface, resulting in a lower percent- 
age yield of 16-Ind for DOTAP/cholesterol-based 
liposome. The fact that we could not detect any 16- 
Ind product (Table 2) for both DOTAP/DOPE and 
DOTMA/DOPE liposomes indicates that the exo- 
surface pHs of the liposomes with DOPE as the aux- 
iliary lipid are probably not as high as the exo-sur- 
face pH of cholesterol-containing liposomes. Such a 
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decrease in exo-surface pH is not unlikely when the 
auxiliary lipid is DOPE. The exo-surface alkalinity 
depends upon the net positive charge of the surface. 
Unlike cholesterol, a substantial portion of DOPE is 
likely to change their head-group nature from nor- 
mal zwitterionic form to negatively charged form, 
even if the surface pH is moderately high (it need 
not be as high as that of cholesterol-containing l po- 
somes). Such negatively charged DOPE will neu- 
tralize a significant portion of the exo-surface posi- 
tive charge, thereby reducing the exo-surface positive 
charge density. However, the observed 16-Ind yields 
in liposomal indazolization for DOTMA-based lipo- 
somes is less than that for DOTMA/cholesterol- 
based liposomes (Table 2). The same trend is also 
observed for DHDAB-based liposomes. Based on 
our non-liposomal indazolization results (Table 1), 
we believe that the observed higher yields of 16-Ind 
for DOTMA/cholesterol and DHDAB/cholesterol 
liposomes compared with liposomes made from 
only DOTMA and DHDAB (Table 2) originate 
from the significantly high exo-surface pH (compared 
to DOTAP-based liposomes). Addition of cholesterol 
to DOTMA- and DHDAB-based liposomes reduces 
the very high exo-surface pH (as in case of DOTAP/ 
cholesterol liposome) to a moderately high value, 
thereby favouring the formation of more 16-Ind. 
Such an increase of indazole yield with decrease of 
pH was observed at the high pH end (pH 14.0 to 
12.5) of the %l-Ind vs. pH correlation (Table 1) dur- 
ing non-liposomal indazolization. 
Clearly, further investigations need to be carried 
out to extract he exact value of the exo-surface pH 
of various cationic liposomes used in gene transfec- 
tion from liposomal exo-surface associated indazoli- 
zation. Our results demonstrate hat 16-Ind yields, 
the indicator for the exo-surface basicities of the cat- 
ionic liposomes commonly used in gene transfection, 
depend significantly on the compositions of the lip- 
osomes. The exo-surfaces of liposomes with choles- 
terol as the auxiliary lipid are more basic than the 
liposomes prepared using DOPE as the auxiliary lip- 
id (Table 2). In their recently published work, Tem- 
pleton et al. [7] have demonstrated that the efficacy 
of cationic liposome-mediated intravenous DNA de- 
livery improves 75-fold to 150-fold when cholesterol 
is used as the neutral lipid (compared with using 
DOPE). Thus, there could be possible correlations 
between the efficacy of liposomal gene transfections 
and the exo-surface basicities of cationic liposomes 
used for transfection. The present method can be 
used in determining the relative exo-surface basicities 
of various cationic liposomes used in gene transfec- 
tion and subsequently, to find any such possible cor- 
relation between the transfection efficiencies of these 
liposomes and their exo-surface basicities. The 
present method can also be used in determining the 
relative interfacial basicities of various cationic re- 
versed micelles which, in turn, can throw new insight 
into the correlation between the activities of interfa- 
cially associated enzymes, e.g., lipases in reversed 
micellar biotechnology across a wide range of solu- 
tion compositions. Studies towards these ends are in 
progress. 
In conclusion, the present work shows that forma- 
tion of a significant amount of 16-Ind in liposome- 
bound indazolization provides evidence for the pres- 
ence of a remarkable alkaline exo-surface in cationic 
liposomes used in gene transfection. 
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